← Back to Screener
Alvotech Warrant (ALVOW)
Price$0.28
Favorite Metrics
Price vs S&P 500 (26W)-81.94%
Price vs S&P 500 (4W)-35.80%
All Metrics
Price vs S&P 500 (YTD)-59.66%
10-Day Avg Trading Volume0.00M
3-Month Avg Trading Volume0.01M
52-Week High$3.00
26-Week Price Return-77.95%
13-Week Price Return-64.20%
3-Month Return Std Dev310.33%
Year-to-Date Return-56.92%
5-Day Price Return-3.45%
Month-to-Date Return-9.68%
Price vs S&P 500 (13W)-64.89%
Beta0.38x
52-Week Low$0.15
Industry Peers — Biological Products(89)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
ALVOWAlvotech Warrant | — | — | — | — | $0.28 |
AMGNAmgen Inc | 5.13x | 9.95% | 73.30% | 2.93% | $349.39 |
GILDGilead Sciences Inc | 5.84x | 2.40% | 78.83% | 133.64% | $138.55 |
ARGXargenx SE American Depositary Shares | 12.46x | 89.56% | 150.91% | — | $828.35 |
BNTXBioNTech SE American Depositary Share | 8.75x | -11.81% | 84.21% | — | $102.12 |
BIIBBiogen Inc. Common Stock | 2.60x | 2.22% | 75.69% | -18.77% | $176.02 |
MRNAModerna, Inc. Common Stock | 11.02x | -39.93% | 70.32% | — | $54.68 |
NBIXNeurocrine Biosciences Inc | 4.49x | 21.45% | 98.18% | 2.31% | $128.41 |
EXELExelixis Inc | 4.96x | 6.85% | 96.39% | 31.10% | $44.38 |
TECHBio-Techne Corp. | 7.60x | 1.64% | 66.60% | -20.58% | $57.36 |
HALOHalozyme Therapeutics, Inc. | 5.74x | 37.55% | 83.62% | 22.89% | $66.64 |
About
Alvotech is an integrated biopharmaceutical company that develops and manufactures biosimilar medicines across multiple therapeutic areas. The company leverages its combined development and manufacturing capabilities to produce high-quality biosimilars while expanding patient access to essential treatments globally.